Skip to Content

Join the 'Cancer' group to help and get support from people like you.

Cancer News

Related terms: Carcinoma, Malignant Disease, Malignant Tumor

High Rate of Antidepressant Use After Cancer

Posted 1 day 3 hours ago by

WEDNESDAY, Oct. 26, 2016 – Treatment for depression and anxiety is nearly twice as common among U.S. cancer survivors as it is for those who never had the disease, a new study finds. Among more than 3,000 adult cancer survivors, 19 percent reported taking medication for anxiety, depression or both, researchers found. But when the research team looked at nearly 45,000 adults with no history of cancer, they found just one in 10 used these medications. "Overall, these findings are sobering," said lead researcher Nikki Hawkins, a behavioral scientist at the U.S. Centers for Disease Control and Prevention. "We've come a long way in treating cancer medically, but these data tell us cancer can take a serious psychological and emotional toll for many years, even after treatment is complete," she said. Hawkins said it's remarkable that nearly one in five cancer survivors is taking medications ... Read more

Related support groups: Depression, Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Major Depressive Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Colorectal Cancer, Dysthymia, Melanoma, Breast Cancer - Adjuvant, Cervical Cancer

Smoking Still Takes Big Toll in U.S. Cancer Deaths

Posted 3 days ago by

MONDAY, Oct. 24, 2016 – Nearly one-third of cancer deaths among Americans aged 35 or older are caused by smoking, and the rate is much higher in the South, a new study finds. Researchers tracking 2014 federal government data found that more than 167,000 cancer deaths among adults 35 and older in 2014 – 28.6 percent – were attributable to cigarette smoking. Most of the states with the highest rates of smoking-linked cancer deaths were in the South, including nine of the top 10 ranked states for men and six of the top 10 ranked states for women, according to the study. Some of these southern states have particularly lax anti-smoking controls in place, the researchers said. "Not surprisingly, states with underfunded tobacco-control programs have the highest prevalence of smoking, as well as the highest proportion of cancer deaths attributable to cigarette smoking," noted Patricia Folan, ... Read more

Related support groups: Cancer, Smoking, Smoking Cessation

FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma

Posted 8 days ago by

October 19, 2016 – The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues. Lartruvo is approved for use with the FDA-approved chemotherapy drug doxorubicin for the treatment of patients with STS who cannot be cured with radiation or surgery and who have a type of STS for which an anthracycline (chemotherapy) is an appropriate treatment. “For these patients, Lartruvo, added to doxorubicin, provides a new treatment option,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research and acting director of the FDA’s Oncology Center of Excellence. “This is the first new therapy approved by the FDA for the initial ... Read more

Related support groups: Cancer, Soft Tissue Sarcoma, Doxorubicin, Lartruvo, Olaratumab

Lartruvo (olaratumab) Approved for Soft-Tissue Cancers

Posted 8 days ago by

WEDNESDAY, Oct. 19, 2016 – Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft-tissue sarcomas, cancers that develop in areas such as the muscles, fat, blood vessels and tendons. Lartruvo has been sanctioned for use with the chemotherapy drug doxorubicin in cases that cannot be treated with radiation or surgery, the FDA said Wednesday in a news release. More than 12,000 new cases of soft-tissue sarcoma are projected to be diagnosed this year and nearly 5,000 people are likely to die from the disease, the agency said, citing estimates from the U.S. National Cancer Institute. Lartruvo is designed to block cell receptors that fuel tumor growth, the FDA said. The drug was evaluated in clinical trials involving 133 people with soft-tissue carcinomas. Average survival among people who took Lartruvo and doxorubicin was 8.2 months, ... Read more

Related support groups: Cancer, Adriamycin, Soft Tissue Sarcoma, Doxorubicin, Dermatofibrosarcoma Protuberans, Liposarcoma, Adriamycin RDF, Kaposi's Sarcoma, Adriamycin PFS, Rhabdomyosarcoma

Little Gains in Efforts to Boost Outpatient Care

Posted 10 days ago by

MONDAY, Oct. 17, 2016 – Efforts to improve the quality of care in the United States have had little impact on many aspects of outpatient care, a new, sweeping analysis shows. The researchers examined the quality of office-based care – meaning visits to physicians, physician assistants and nurse practitioners – between 2002 and 2013. Ongoing deficits in care "pose serious hazards to the health of the American public," the study authors concluded. One in four eligible Americans, for example, failed to receive recommended cancer screening. "That didn't change at all over 10 years and, in fact, got worse in places like mammography and cervical cancer screening," said study author Dr. David Levine. Levine is an internist and research fellow at Brigham & Women's Hospital and Harvard Medical School in Boston. Levine and his team also identified wasteful spending and possible harm due to ... Read more

Related support groups: Diabetes, Type 2, Cancer, Colonoscopy, Cervical Cancer, Breast Cancer, Prevention, Body Imaging

More Evidence Linking Obesity to Liver Cancer

Posted 13 days ago by

FRIDAY, Oct. 14, 2016 – Having a large waistline, a high body mass index (BMI) and type 2 diabetes, may raise your risk for liver cancer, a new study suggests. "We found that each of these three factors was associated, robustly, with liver cancer risk," said study co-author Peter Campbell. He's strategic director of digestive system cancer research at the American Cancer Society. Liver cancer rates have roughly tripled in the United States since the mid-1970s, "and the prognosis for patients diagnosed with this type of cancer is especially grim," Campbell said. He and his colleagues examined data on 1.57 million adults from 14 U.S. studies to look for an association between obesity and type 2 diabetes and liver cancer. None of the participants had cancer when the study began. Over time, 6.5 percent of the participants were diagnosed with type 2 diabetes, which is an obesity-related ... Read more

Related support groups: Obesity, Cancer, Hepatocellular Carcinoma, Liver and Pancreatic Disease, Hepatic Tumor

Freeze Therapy: An Alternative to Breast Cancer Surgery?

Posted 16 days ago by

TUESDAY, Oct. 11, 2016 – A freezing technique known as cryoablation might be a viable alternative to lumpectomy for treating small, early stage breast cancers, researchers report. In the small study of 86 patients, "cryoablation was shown to successfully [treat] the majority of small breast cancers with few side effects or complications," said study co-author Dr. Deanna Attai. She's an assistant clinical professor of surgery at the University of California, Los Angeles David Geffen School of Medicine. Using this minimally invasive approach to destroy cancer cells, there should be little to no change in the appearance of the breast, said Attai, immediate past president of the American Society of Breast Surgeons. The major risk, Attai said, is not killing all the cancerous cells. Another surgeon noted that although further research is still needed, cryoablation appears to be "a potential ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Renal Cell Carcinoma, Breast Cancer - Adjuvant, Breast Cancer, Prevention

For Medical Diagnoses, Doctors Still Trounce Computers

Posted 16 days ago by

TUESDAY, Oct. 11, 2016 – Real doctors are still better at figuring out what's ailing someone than sophisticated symptom-checking websites and smartphone apps, according to a new study. Physicians were twice as likely to get the right diagnosis on the first try as 23 popular symptom-checking computer programs, said senior researcher Dr. Ateev Mehrotra. The gap was widest when it came to more complex health problems, said Mehrotra, an associate professor of health care policy and medicine at Harvard Medical School. But across the board, "the physicians performed much better in terms of diagnostic accuracy," Mehrotra said. The study involved 234 physicians and 23 computer symptom checkers. They were presented with 45 vignettes involving hypothetical patients and were asked to determine the illness each person likely had. The symptom checkers included web offerings from places like the ... Read more

Related support groups: Cancer, Heart Disease

Americans Are Changing Their Supplements of Choice

Posted 16 days ago by

TUESDAY, Oct. 11, 2016 – Traditional multivitamins are falling out of favor among Americans, while supplements such as vitamin D, fish oil and probiotics are gaining ground, a new study finds. Researchers found that between 1999 and 2012, Americans' overall use of supplements remained stable. Slightly more than half of adults said they took vitamins, minerals or some other type of dietary supplement. What's changed are the products of choice. Multivitamins and many individual vitamins and minerals are less popular, as are botanicals such as echinacea, ginseng and garlic extracts, the investigators found. On the other hand, more people are using vitamin D, omega-3 fatty acids and probiotics – "good" bacteria said to benefit the digestive system. Researchers said the findings make sense. "I did expect to see that vitamin D use would go up, and that fish oil would go up," said lead ... Read more

Related support groups: Cancer, Vitamin/Mineral Supplementation and Deficiency, Prevention of Cardiovascular Disease, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Cardiovascular Risk Reduction, Caltrate 600 with D, Calcium/Vitamin D, Oysco 500 with D, Citracal + D, Citracal Petites, Calcium 600 D, Citracal Creamy Bites, Calcet, Oyster Shell Calcium, Calcarb with D, Sedecal D, Calcio Del Mar, Dical-D, Caltrate Colon Health, Oysco D with Calcium

U.S. Life Expectancy Lags Behind Other Wealthy Nations

Posted 7 Oct 2016 by

THURSDAY, Oct. 6, 2016 – The United States lags behind other advanced nations when it comes to infant mortality and the life expectancy of its citizens, according to a comprehensive review of global health statistics. The health of U.S. citizens is specifically challenged by smoking, diabetes, high blood pressure, drug abuse and gun violence, said study co-author Dr. Mohsen Naghavi. He's a professor with the Institute for Health Metrics and Evaluation at the University of Washington in Seattle. The United States isn't meeting the high expectations set by the country's wealth and the amount it spends on health care, mainly because not all U.S. citizens benefit equally from their nation's advantages, Naghavi said. "This comes from inequality in access to health care, along with other social and economic factors," he said. Infant mortality in the United States amounted in 2015 to six ... Read more

Related support groups: Cancer, Diabetes Mellitus

Steep Rise in Price of Older Cancer Drugs

Posted 6 Oct 2016 by

THURSDAY, Oct. 6, 2016 – Many older cancer drugs took a bigger bite out of Medicare and older Americans' wallets last year than five years earlier, a new analysis finds. After adjusting for inflation, nearly two-thirds of 86 cancer medicines in the study had price increases between 2010 and 2015, researchers reported. Eleven drugs more than doubled in price, and older drugs increased more than newer drugs, the study found. The study included oral and intravenous chemotherapy drugs covered by Medicare Part B. Medicare is the federal health insurance plan for people 65 or older. "Higher costs lead to higher copays," said study co-author Dr. Sham Mailankody. He's a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City. "And empiric research suggests higher copays lead to treatment delays or discontinuation," he added. Patients with Medicare Part B coverage are ... Read more

Related support groups: Cancer, EpiPen, Cytoxan, Cyclophosphamide, Daraprim, Neosar, Cytoxan Lyophilized

Cancer Patients in Poorer Countries Often Go Without Radiation

Posted 2 Oct 2016 by

THURSDAY, Sept. 29, 2016 – Many cancer patients in low- and middle-income nations who would benefit from radiation treatment don't receive it, a new study finds. "In Ghana and the Philippines, for example, about eight in 10 cancer patients who need radiation therapy will not receive needed treatment," said study co-author Dr. Elena Fidarova, a researcher at the International Atomic Energy Agency in Vienna, Austria. She and her colleagues analyzed data from nine nations: Costa Rica, Ghana, Malaysia, the Philippines, Romania, Serbia, Slovenia, Tunisia and Uruguay. Overall, about five out of 10 cancer patients in these countries require radiation therapy to shrink tumors and kill cancer cells. But up to half of them do not have access to it, the researchers found. In individual nations, the rates of patients who can benefit from radiation therapy but do not receive it ranged from 18 to 82 ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Brain Tumor, Bladder Cancer, History - Radiation Therapy

A Doctor's Words Key to Whether Child Gets HPV Vaccine

Posted 2 Oct 2016 by

FRIDAY, Sept. 30, 2016 – The language doctors use when recommending the human papillomavirus (HPV) vaccine can influence whether parents will have their children immunized, a new study finds. HPV causes most cases of cervical cancer and a large percentage of vaginal, vulvar, anal, penile and oropharyngeal cancers. The U.S. Centers for Disease Control and Prevention recommends boys and girls receive the three-dose HPV vaccination beginning at age 11 or 12. As of 2015, only 42 percent of girls and 28 percent of boys ages 13 to 17 had completed the HPV vaccine series, according to the CDC. Previous research found that doctors' recommendations play a major role in whether parents have their children vaccinated. In this new study, researchers examined if specific language used by doctors affects parents' decisions. The study included more than 1,500 parents. Their children were between the ... Read more

Related support groups: Cancer, Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Head and Neck Cancer, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

Knowing Their Breast Cancer Risk May Empower Teens

Posted 29 Sep 2016 by

THURSDAY, Sept. 29, 2016 – Knowing they have a family history of breast cancer or a high-risk gene mutation doesn't lead to increased anxiety or depression in teen girls, a new study finds. These teens may actually have greater self-esteem and a better understanding of cancer risk than their peers, researchers said. "Overall, girls in families with a history of breast cancer seem to cope pretty well over time," said study author Dr. Angela Bradbury. She is an assistant professor of hematology/oncology at the University of Pennsylvania's Abramson Cancer Center in Philadelphia. "They do worry more about breast cancer than their peers do, particularly as they get older, but that doesn't seem to impact them in terms of depression, anxiety and general psychosocial adjustment," Bradbury explained in a university news release. The study included 320 girls, aged 11 to 19. Of those girls, 208 ... Read more

Related support groups: Cancer, Breast Cancer, Breast Cancer, Prevention

Exercise May Not Lower Women's Risk of Multiple Sclerosis

Posted 29 Sep 2016 by

THURSDAY, Sept. 29, 2016 – Regular workouts may cut a woman's chances for heart disease and certain cancers, but new research suggests they won't lower the risk of multiple sclerosis (MS). The new study "did not provide evidence to support" the notion that exercise lowers MS risk, said study author Kassandra Munger, of the Harvard School of Public Health in Boston. For the study, Munger's group tracked data on more than 193,000 American women involved in the Nurses' Health Study and Nurses' Health Study 2. These women were followed for up to 20 years. They had to fill out questionnaires regarding their current physical activity as well as the exercise they got when they were growing up. Munger's team used this information to calculate the number of hours the women exercised each week. Over the course of the study, 341 of the women were diagnosed with MS. After considering a number of ... Read more

Related support groups: Cancer, Multiple Sclerosis, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Prostate Cancer, Colorectal Cancer, Renal Cell Carcinoma, Ovarian Cancer, Brain Tumor, Pancreatic Cancer, Bladder Cancer, Skin Cancer, view more... Endometrial Cancer, Head and Neck Cancer, Cervical Cancer, Hypercalcemia of Malignancy, Soft Tissue Sarcoma, Lung Cancer, Neuroendocrine Carcinoma, Testicular Cancer, Stomach Cancer, Gastric Cancer, Osteosarcoma, Urinary Tract Tumors, Solid Tumors, Malignant Pleural Mesothelioma, Adrenal Cortical Carcinoma, Neuroblastoma, Ewing's Sarcoma, Fallopian Tube Cancer, Malignant Pleural Effusion, Peritoneal Cancer, Multicentric Castleman’s Disease, Choriocarcinoma, Urinary Tract Cancer, Merkel Cell Carcinoma, Tumor Lysis Syndrome

Related Drug Support Groups

fluorouracil, carboplatin, Cytoxan, cyclophosphamide, Leukeran, vincristine, Adriamycin, vinblastine, doxorubicin, view more... topotecan, Hycamtin, chaparral, etoposide, Velban, Mustargen, amifostine, Oncovin, Adrucil, thiotepa, fludarabine, chlorambucil, levamisole, Tepadina, Vincasar PFS, Cytoxan Lyophilized, Adriamycin RDF, Ergamisol, Adriamycin PFS, Thioplex, Carboplatin Novaplus, Cosmegen, Ethyol, mechlorethamine, ifosfamide, dactinomycin, Paraplatin, Neosar, Fludara, Toposar, Etopophos, VePesid, Ifex